Clinical Trial

Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
chemical pleurodesis using doxycycline is an acceptable and commonly employed palliation for malignant pleural effusion. Rotation of patient during pleurodesis using the powder from doxycycline capsule is still practiced in some centers. The benefit of rotation practice in pleurodesis can be verified after properly designed study on the outcome of pleurodesis with rotation and non-rotation by chest ultrasound assessment
Trial Details
NCT Number NCT07147270
Lead Sponsor Ain Shams University
Conditions Effect of Patient Rotation on Pleurodesis Success and Patient Comfort, Malignant Pleural Effusion, Pleurodesis
Enrollment 30 participants
Start Date 2025-05-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-08-29